NASDAQ:AXNX
Delisted

Axonics Modulation Technologies Stock News

etoro logo Buy AXNX
*Your capital is at risk
$70.98
+0 (+0%)
At Close: Feb 13, 2025

Desembargador suspende investiga

09:49pm, Sunday, 19'th Jul 2020
O desembargador Paulo Espirito Santo, do Tribunal Regional Federal da 2
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that sm
Harel Insurance Investments & Financial Services Ltd. bought a new stake in shares of Axonics Modulation Technologies Inc (NASDAQ:AXNX) in the second quarter, according to the company in its most rece
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for the treatment of
Axonics Modulation Technologies Inc (NASDAQ:AXNX) was the recipient of some unusual options trading activity on Monday. Investors bought 5,054 call options on the stock. This represents an increase of
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for the treatment of
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affimed NV (NASDAQ: AFMD)...
Geode Capital Management LLC lifted its position in shares of Axonics Modulation Technologies Inc (NASDAQ:AXNX) by 19.4% in the 1st quarter, according to the company in its most recent 13F filing with
JPMorgan Chase & Co. increased its position in Axonics Modulation Technologies Inc (NASDAQ:AXNX) by 24.2% in the 1st quarter, according to the company in its most recent 13F filing with the Securities
Squarepoint Ops LLC cut its holdings in shares of Axonics Modulation Technologies Inc (NASDAQ:AXNX) by 44.7% during the 1st quarter, according to the company in its most recent disclosure with the Sec
Needham analyst Michael Matson assigned a Buy rating to Hologic (HOLX – Research Report) today and set a price target
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for the treatment of
Caso foi mostrado no Fantástico e cita o Juiz Márcio José do Carmo e o advogado Gustavo Santos Simeão.
Serão instaladas barreiras nos acessos às avenidas Sete de Setembro e Joana Angélica, assim como no bairro Dois de Julho.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE